This literature review provides an overview of use of environmental samples (ES) such as faeces, water, air, mud and swabs of surfaces in avian influenza (AI) surveillance programs, focussing on effectiveness, advantages and gaps in knowledge. ES have been used effectively for AI surveillance since the 1970s. Results from ES have enhanced understanding of the biology of AI viruses in wild birds and in markets, of links between human and avian influenza, provided early warning of viral incursions, allowed assessment of effectiveness of control and preventive measures, and assisted epidemiological studies in outbreaks, both avian and human. Variation exists in the methods and protocols used, and no internationally recognized guidelines exist on the use of ES and data management. Few studies have performed direct comparisons of ES versus live bird samples (LBS). Results reported so far demonstrate reliance on ES will not be sufficient to detect virus in all cases when it is present, especially when the prevalence of infection/contamination is low. Multiple sample types should be collected. In live bird markets, ES from processing/selling areas are more likely to test positive than samples from bird holding areas. When compared to LBS, ES is considered a cost-effective, simple, rapid, flexible, convenient and acceptable way of achieving surveillance objectives. As a non-invasive technique, it can minimize effects on animal welfare and trade in markets and reduce impacts on wild bird communities. Some limitations of environmental sampling methods have been identified, such as the loss of species-specific or information on the source of virus, and taxonomic-level analyses, unless additional methods are applied. Some studies employing ES have not provided detailed methods. In others, where ES and LBS are collected from the same site, positive results have not been assigned to specific sample types. These gaps should be remedied in future studies.
Unexpected pathogen transmission between animals, humans and their shared environments can impact all aspects of society. The Tripartite organisations—the Food and Agriculture Organization of the United Nations (FAO), the World Health Organization (WHO), and the World Organisation for Animal Health (WOAH)—have been collaborating for over two decades. The inclusion of the United Nations Environment Program (UNEP) with the Tripartite, forming the ‘Quadripartite’ in 2021, creates a new and important avenue to engage environment sectors in the development of additional tools and resources for One Health coordination and improved health security globally. Beginning formally in 2010, the Tripartite set out strategic directions for the coordination of global activities to address health risks at the human-animal-environment interface. This paper highlights the historical background of this collaboration in the specific area of health security, using country examples to demonstrate lessons learnt and the evolution and pairing of Tripartite programmes and processes to jointly develop and deliver capacity strengthening tools to countries and strengthen performance for iterative evaluations. Evaluation frameworks, such as the International Health Regulations (IHR) Monitoring and Evaluation Framework, the WOAH Performance of Veterinary Services (PVS) Pathway and the FAO multisectoral evaluation tools for epidemiology and surveillance, support a shared global vision for health security, ultimately serving to inform decision making and provide a systematic approach for improved One Health capacity strengthening in countries. Supported by the IHR-PVS National Bridging Workshops and the development of the Tripartite Zoonoses Guide and related operational tools, the Tripartite and now Quadripartite, are working alongside countries to address critical gaps at the human-animal-environment interface.
Purpose: Middle East Respiratory Syndrome Coronavirus (MERS-CoV) remains an emerging disease threat, with regular reports of human cases on the Arabian Peninsula, driven by recurring camel-to-human transmission events. A prophylactic vaccine under development has been found to greatly reduce shedding in dromedaries, but there are major gaps in our quantitative understanding of the epidemiology of MERS-CoV in dromedary populations. The purpose of our work is to develop a mathematical model of MERS-CoV transmission in camels in order to address these gaps and to eventually inform the development of evidencebased animal vaccination strategies.Methods & Materials: After reviewing publicly available data on camel demography and epidemiology of MERS-CoV in camels, we developed a stochastic, age-structured mathematical model of MERS-CoV transmission in single homogenous camel populations, and between coupled sub-populations.Results: We show that if immunity is completely protective against future infection, a basic reproduction number (R 0 ) of 6 reproduces reported patterns of age-stratified seroprevalence observed in camel populations sampled in the Arabian Peninsula and North Africa. If immunity offers only partial protection, we estimate that R 0 is approximately 3. In large modelled populations where transmission persists long-term, epidemics are predicted to have an annual periodicity driven by seasonal births. Allowing reinfection (due to partial immunity) enhances persistence but disease extinction by chance is still expected in well-mixed populations of less than 1000 animals. Hence, we predict that single herds are unlikely to be able to sustain MERS-CoV transmission. Using a meta-population model of multiple coupled small populations, we show that transmission can persist in the population as a whole due to random reintroduction of virus into populations in which transmission has previously ceased via animal movements. Conclusion:We conclude that the R 0 of MERS-CoV in camels is in the range 3-6, indicating moderate transmissibility. A metapopulation model of MERS-CoV transmission reproduces the long-term persistence of MERS-CoV in camel populations in Africa and the Arabian Peninsula and may be useful for simulating camel vaccination strategies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.